Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Tuberculosis Has Shaped Medicine and Society

Simon M. Helfgott, MD  |  Issue: May 2017  |  May 17, 2017

In contrast, older human infections are often characterized by slow progression to disease, sometimes involving reactivation after many years of latent or asymptomatic infection; these characteristics have been proposed to reflect adaptation to low host population densities by allowing repletion of the reservoir of susceptible individuals.

MTB is blessed with both traits: crowded, dense populations have proved to be fertile killing fields for the organism, but in those situations where MTB is so adept in wiping out all of its infected hosts, it can still rely on its pattern of chronic progression, latency and reactivation for it to carry on in perpetuity.5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

MTB infection is transmitted through aerosols, whereby droplet nuclei containing one to three bacilli are inhaled and penetrate deep into the lung. In the alveolar sacs, it is engulfed by alveolar macrophages; however, the bacilli have a range of systems to circumvent the antibacterial properties of the macrophage, allowing it to reside and replicate in a protected intracellular niche.6 As the bacterial load increases, T cells are recruited to the site of infection, where they attract and activate more macrophages in an effort to eradicate the pathogen. This escalation of the immune response leads to the generation of a granulomatous lesion, or tubercle, the hallmark of MTB pathology.

Most infected individuals can successfully contain the pathogen in these lesions, leading to a state of latent infection with no obvious clinical signs. However, depending on the host’s health and social milieu, the infection may pierce the protective barriers and infect the host. Among our most critical shields is the potent cytokine tumor necrosis factor (TNF), which is central to the pathogenesis of a host of inflammatory diseases. When tangling with TNF, tread carefully.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

‘Modern experimental work on the production of models of autoimmune disease in laboratory animals is almost wholly the creation of Freund’s complete adjuvant.’ —Sir Macfarlane Burnet

Harnessing The Power of MTB

The scourge of TB intensified the need for better disease prevention strategies. Working together at the Pasteur Institute in Lille, France, Albert Calmette, MD, a bacteriologist, and Camille Guerin, DVM, a veterinarian, isolated a virulent strain of M. bovis (closely related to the human MTB) from the udder of an infected cow. There were some technical issues: mycobacterium cultures showed a strong tendency to clump, and to prevent adhesion, their recipe required the virulent bovine-type tubercle bacilli to be cultured in a medium consisting of cow bile, potatoes and glycerin, which allowed for a gradual loss of its virulence.7 However, the German occupation of Lille during World War I greatly increased the cost of potatoes and made it challenging for Drs. Calmette and Guerin to obtain suitable ox bile from the abattoir. By grace of the veterinary surgeons of the German occupying force, their cultures survived.8

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Caseation necrosisHistoryImmunologyrheumatologistrheumatologyTreatmentTuberculosis

Related Articles

    ASIA: A New Way to Put the Puzzle Together

    June 13, 2011

    Autoimmune (autoinflammatory) syndrome induced by adjuvants provides a diagnostic framework for enigmatic conditions

    Chronic Reactive Arthritis Secondary to Intravesical Bacillus Calmette–Guerin in Bladder Carcinoma

    September 8, 2016

    A 50-year-old man with history of superficial bladder carcinoma presented to our rheumatology clinic for a three-year history of symmetric polyarthralgias. He had undergone multiple transurethral resection of bladder tumor procedures and bacillus Calmette–Guerin (BCG) treatments. Prior to receiving BCG, he was fully functional and employed. Days after receiving his second BCG treatment, he developed…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Case Report: A Non-Tuberculous Mycobacterial Infection

    January 20, 2021

    Tumor necrosis factor-α inhibitors (TNFi’s) have emerged as an integral part of therapeutic strategies for several rheumatic diseases. TNF-α is a pro-inflammatory cytokine implicated in the pathogenesis of rheumatoid arthritis (RA), seronegative spondyloarthropathies and inflammatory bowel disease (IBD). It also plays a central role in the immune response to mycobacterial infection.  Many biologic agents, particularly…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences